ConductScience.org, home

Paper2822243

Depressed natural cytotoxicity but normal natural killer cytotoxic factor (NKCF) production by mononuclear cells derived from patients with hepatocellular carcinoma.

Brookes RH and 2 others. Cancer Immunol Immunother, 1987. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Depressed natural cytotoxicity but normal natural killer cytotoxic factor (NKCF) production by mononuclear cells derived from patients with hepatocellular carcinoma. Papers, record 2822243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2822243

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Depressed natural cytotoxicity but normal natural killer cytotoxic factor (NKCF) production by mononuclear cells derived from patients with hepatocellular carcinoma.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.5
iCite
Revised in PubMed
2024-04-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brookes RHR H
2Kew MCM C
3Rabson ARA R

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Killer Cells, NaturalMajor topic
Leukocytes, MononuclearMajor topic
Liver NeoplasmsMajor topic
Protein BiosynthesisMajor topic
ProteinsMajor topic
Adult
Cytotoxicity, Immunologic
Humans
Killer Factors, Yeast
Lysosomes
Middle Aged
Monensin

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13093586Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.J Immunol1986https://conductscience.org/library/papers/3093586PubMed
23958135Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells.J Clin Immunol1986https://conductscience.org/library/papers/3958135PubMed
36491292
Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
J Immunol1984https://conductscience.org/library/papers/6491292PubMed
46257729Monensin and FCCP inhibit the intracellular transport of alphavirus membrane glycoproteins.J Cell Biol1980https://conductscience.org/library/papers/6257729PubMed
52427588
Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.
J Immunol1986https://conductscience.org/library/papers/2427588PubMed
66822733Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.J Immunol1983https://conductscience.org/library/papers/6822733PubMed
7374818Do macrophages destroy nascent tumors?J Natl Cancer Inst1979https://conductscience.org/library/papers/374818PubMed
87226236The cytotoxic activity of human natural killer cells requires an intact secretory apparatus.Cell Immunol1981https://conductscience.org/library/papers/7226236PubMed
96835377Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells.Nature1983https://conductscience.org/library/papers/6835377PubMed
106968289Target-effector cell interaction in the natural killer cell system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes.Immunology1980https://conductscience.org/library/papers/6968289PubMed
11103883Comparative studies of intracellular transport of secretory proteins.J Cell Biol1978https://conductscience.org/library/papers/103883PubMed
126288803
Differential effects of various pharmacological agents on the cytolytic reaction mechanism of the human natural killer lymphocyte: further resolution of programming for lysis and KCIL into discrete stages.
J Immunol1982https://conductscience.org/library/papers/6288803PubMed
132985238Defective interleukin-1 production by natural killer cells of patients with cancer.Cancer Immunol Immunother1985https://conductscience.org/library/papers/2985238PubMed
143760569Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.J Immunol1986https://conductscience.org/library/papers/3760569PubMed
156263497Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts.Cell1981https://conductscience.org/library/papers/6263497PubMed
166195261Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor.J Immunol1983https://conductscience.org/library/papers/6195261PubMed
176609314Human large granular lymphocytes are potent producers of interleukin-1.Nature1984https://conductscience.org/library/papers/6609314PubMed
182993420The role of interleukin 1 (IL 1) in tumor-NK cell interactions: correction of defective NK cell activity in cancer patients by treating target cells with IL 1.J Immunol1985https://conductscience.org/library/papers/2993420PubMed
197204975Selective lysis of NK-sensitive target cells by a soluble mediator released from murine spleen cells and human peripheral blood lymphocytes.J Immunol1981https://conductscience.org/library/papers/7204975PubMed
202420467Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity.Cell1986https://conductscience.org/library/papers/2420467PubMed

See all 22 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2822243

GET https://conductscience.org/api/papers/v1/2822243/references?page=2